Avanir

Avanir is a Biopharmaceutical company focused on bringing innovative medicines to patients with central nervous system disorders of high unmet medical need. Avanir products include NUEDEXTA™, treatment for pseudobulbar affect, and ONZETRA™ XSail™, treatment of acute migraine.  Avanir has four additional indications in development. For more information: http://www.avanir.com.